Nanomedicine: Where Few CDMOs Dare To Go

Few contract development and manufacturing organizations take on nanomedicine, and the reasons say a lot about what the work demands. Customized nanoparticle products for medical applications must move from preclinical studies to commercialization under cGMP, and the partner chosen along the way shapes how that path unfolds. Ardena's offering rests on more than 12 years of GMP manufacturing, a state-of-the-art facility, and over 100 nanomedicine programs, framed around the critical challenges facing the healthcare industry.

Access the full brochure to scan through the nanomedicine services, as well as consider how the approach might fit your own molecule.